INTRODUCTION
Adenylate cyclase is regulated by GTP in a biphasic fashion. Low concentrations of the guanine nucleotide are stimulatory, whereas higher concentrations inhibit the enzyme (Londos et al., , 1981 Cooper, 1983) . It is now recognized that these effects of GTP are mediated by the guanine-nucleotide-binding proteins (G-proteins) Gs and G. (Casey & Gilman, 1988) . In addition, in the presence of GTP, Gi is able to mediate the inhibition of adenylate cyclase that occurs when various cell surface receptors are occupied by agonists. A number of studies have shown that these inhibitory events can be modified in different physiological states. In adipose tissue, hypothyroidism enhances inhibition of adenylate cyclase both by GTP and by adenosine acting through A1-type adenosine receptors (Malbon et al., 1985) . This change is not brought about by an increase in adenosine receptor numbers (Chohan et al., 1984; Malbon et al., 1985) but is associated with an increased abundance of the asubunit of Gi in fat-cell membranes Ros et al., 1988) . By contrast, decreased Gimediated inhibition of rat liver adenylate cyclase by guanylyl 5-imidodiphosphate is found in streptozotocin diabetes (Gawler et al., 1987) and in the (fa/fa) type of inherited obesity (Houslay et al., 1989) .
In the central nervous system, many presynaptic receptors that mediate inhibition of neurotransmitter release, including A1 adenosine, a2-adrenergic, opiate, GABAB, muscarinic cholinergic and dopamine D2 receptors, are also able to mediate inhibition of adenylate cyclase and lowering of cyclic AMP levels (Fredholm & Dunwiddie, 1988) . In the case of the A1 adenosine receptor, inhibition of adenylate cyclase has been noted in several regions of the brain, with the effect being seen in both neuronal and glial cell types (Cooper et al., 1980; Ebersolt et al., 1983) .
The extent to which lowering of cyclic AMP contributes to inhibition of neurotransmitter release by adenosine is unresolved (see reviews by Silinsky, 1986; Dunwiddie & Proctor, 1987; Fredholm & Dunwiddie, 1988) and other mechanisms such as inhibition of voltage-sensitive Ca2" channels or increasing K+ conductance are also implicated Trussell & Jackson, 1985 Dolphin et al., 1986; Scott & Dolphin, 1987) .
Following findings from this and other laboratories that hypothyroidism enhances the inhibitory effects of Gi-coupled agonists in fat cells (Malbon et al., 1985; Saggerson, 1986; Milligan et al., 1987; Ros et al., 1988) , and in view of known behavioural changes in hypothyroidism (Gold et al., 1981; Reus, 1986) (Chohan et al., 1984; Saggerson & Carpenter, 1986) . These animals were killed 4 weeks after commencement of this treatment, when they weighed 140-170 g. Euthyroid controls fed on a normal diet were also 8 weeks old at time of death, when they weighed 260-280 g. Isolation of synaptosomal membranes Rats were stunned and then killed by decapitation. Forebrains were rapidly removed and collected in icecold 0.32 M-sucrose medium containing 10 mM-Tris/HCI buffer (pH 7.4) and 1 mM-EDTA. They were then weighed, cut into small pieces and washed with the same medium to remove blood. Homogenates were prepared in a Potter-Elvehjem glass homogenizer using a Teflon pestle (six up-and-down strokes at 500 rev./min with a radial clearance of 0.2 mm). The homogenate was diluted with the ice-cold sucrose medium to give a final concentration of 11-15% (w/v) and then fractionated to obtain synaptosomes essentially as described by Booth & Clark (1978) with some minor modifications. After an initial centrifugation at 1500 ga,v for 3 min, the resulting supernatant was centrifuged at 18000 gv for 10 min. The pellet was resuspended in 5 ml of the sucrose medium and then mixed with 25 ml of 120 Ficoll medium [120 (w/w) Ficoll/0.32 M-sucrose/10 mM-Tris/HCl buffer (pH 7.4)/1 mM-EDTA]. Portions (5 ml) of these suspensions were pipetted into 14 ml centrifuge tubes followed by a 2.5 ml layer of 700 Ficoll medium [700 (w/w) Ficoll/0.32 M-sucrose/ 10 mM-Tris/HCl buffer (pH 7.4)/ 1 mM-EDTA] and then a 2.5 ml layer of 0.32 Msucrose medium containing 10 mM-Tris/HCl buffer (pH 7.4) and 1 mM-EDTA. After centrifugation at 110000 gav the synaptosomal fraction, which banded at the lower interface, was removed and resuspended in 5 mM-Tris/HCl buffer (pH 8.0) containing I mM-EDTA. After sonication for 30 s, the suspension was left on ice for 30-45 min to achieve lysis of the synaptosomes, followed by centrifugation at 105 000 g,v for 45 min. The resulting synaptic membrane fraction was resuspended in 2-3 ml of 50 mM-Tris/HCl buffer (pH 7.4) containing 1 mM-EDTA, and stored at -80 'C. . 32P and 3H were then measured by dual-label liquid scintillation counting in a cocktail consisting of 4 g of 2,5-bis-(5-t-butylbenzoxazol-2-yl)-thiophen/litre in toluene/Triton X-100 (2: 1, v/v). Preliminary experiments established that the assay procedure was satisfactory in our hands with a 63 00 average recovery of cyclic deoxyAMP that had negligible contamination by deoxyATP or deoxyAMP. The 32P-labelled reaction product co-chromatographed with authentic cyclic deoxyAMP on t.l.c. using a solvent mixture of propan-2-ol: ethyl acetate: 8 M-ammonia (9:4:3, by vol.) (Arch & Newsholme, 1976) . Assays were linear for at least 20 min in the presence and absence of forskolin, GTP or Na+ in both the euthyroid and the hypothyroid states.
Assay of radioligand binding to membranes The methods were basically those described by Lohse et al. (1984) . Prior to assays, synaptosomal membranes were diluted to a concentration of 1 mg/ml using 50 mMTris/HC1 buffer (pH 7.4) and preincubated for 30 min at 37°C with adenosine deaminase (3 units/ml) to remove endogenous adenosine. To measure saturation binding of PIA, membranes (100 ,g of protein) were then incubated with the required concentration of (-)N6-R-[G-3H]phenylisopropyladenosine (0.25-50 nM) in a total volume of 1.0 ml of 50 mM-Tris/HCI buffer (pH 7.4) for 45 min at 37 'C. The membranes were separated from unbound radioactivity by vacuum filtration through Whatman GF/B glass fibre filters. The filters were immediately washed twice with 5 ml of ice-cold 50 mMTris/HCl buffer (pH 7.4) and then counted for radioactivity in a cocktail consisting of 4 g of 2,5-bis-(5-t-butylbenzoxazol-2-yl)thiophen/litre plus 80 g of naphthalene/litre dissolved in toluene/2-methoxyethanol (3:2, v/v). (Colquhoun, 1971 ).
On input of data as means + S.E.M., the program estimated KD and Bmax and, in the case of competition curves, non-specific binding. Statistical analysis to assess the appropriateness of one-or two-site models of binding was performed using a partial F test (Munson & Rodbard, 1980) .
RESULTS AND DISCUSSION Membrane preparations
Preliminary experiments (Mazurkiewicz & Saggerson, 1989) established that the synaptosomal preparations were relatively free from contamination by marker enzymes for myelin and mitochondria (2',3'-cyclic nucleotide phosphodiesterase and succinate dehydrogenase respectively). Furthermore, hypothyroidism did not alter these relative distributions. Activation of adenylate cyclase by forskolin
Rather than study the effects of GTP and PIA on basal adenylate cyclase, we chose to use forskolin-activated enzyme as the test system. It was therefore necessary at the outset to investigate whether hypothyroidism altered the effect of forskolin on the enzyme. This was not found to be so. Dose-response curves for activation by forskolin are shown in Fig. 1 . Hill coefficients of less than 1 were observed in all cases, consistent with high-and low-affinity effects of the diterpene reported previously (Green & Clark, 1982; Seamon et al., 1984; Seamon & Daly, 1985) . Although Na+ was found to decrease adenylate cyclase activity, this effect being more pronounced in the euthyroid case, neither hypothyroidism nor addition of 100 mM-NaCl appreciably altered the Hill coefficients or the calculated EC50 values. In addition, hypothyroidism did not significantly alter adenylate cyclase activity at any forskolin concentration in the presence or absence of Na+. All further studies of the cyclase in either state were performed using 10 /Mforskolin. Effects of GTP upon adenylate cyclase activity
In the absence of Na+, GTP at concentrations in excess of 1 /LM significantly decreased forskolin-stimulated cyclase activity (Fig. 2a) . By contrast with the fat-cell system (Malbon et al., 1985) , hypothyroidism did not enhance the inhibitory effect of GTP in the absence of Na+. Although quantitative comparisons cannot easily be made between different systems, there is general agreement that Na+ attenuates the inhibitory effect of GTP (Cooper et al., 1980 (Cooper et al., , 1982 Londos et al., 1981; Koski et al., 1982; Jacobs et al., 1984) . By contrast, Na+ amplifies the degree of inhibition seen in the presence of receptor agonists and GTP (Blume et al., , 1980 Lichtshtein et al., 1979; Jacobs et al., 1981; Londos et al., 1981) . Fig. 2 (b) indeed shows that addition of 100 mmNaCl abolished the inhibitory effect of GTP in membranes from euthyroid rats. However, in membranes from hypothyroid animals, GTP was still able to inhibit adenylate cyclase, i.e. GTP was able to overcome the attenuating effect of Na+. Effects of PIA upon adenylate cyclase activity In order to facilitate the detection of an inhibitory action of PIA, the assays of the cyclase were performed throughout using deoxyATP as the substrate and in the presence of a high concentration of adenosine deaminase. These precautions minimize effects due to endogenous adenosine. Fig. 3 shows that PIA significantly decreased forskolin-stimulated cyclase activity when GTP and Na+ were present. As found previously with brain membranes (Cooper et al., 1980;  Vol. 263 indicated by: *P < 0.05, **P < 0.01, ***P < 0.005 (paired differences). In addition, the effect of 10 ,#M-PIA was significantly greater in hypothyroidism than in the euthyroid state (P < 0.05 by an unpaired test). *, Euthyroid; 0, hypothyroid. Ebersolt et al., 1983) , inhibitory effects of PIA were relatively slight compared with the effect seen in the fatcell system (Malbon et al., 1985) . Nevertheless, hypothyroidism significantly enhanced the inhibitory effect of PIA upon the brain adenylate cyclase activity (Fig. 3) .
Saturation binding of 13HIPIA to membranes Fig. 4 shows that [3H]PIA bound to synaptosomal membranes from normal animals with a Bmax value of 600 fmol/mg. Values of 810 fmol/mg and 740 fmol/mg have previously been reported by Trost (1980) and Lohse et al. (1984) respectively. The binding was fitted to a single class of binding site by computer analysis. This conclusion is supported by the linearity of the Scatchard plot (r = -0.96, P < 0.001). The KD of 3.3 nm was not dissimilar to the values of 5.1 nm and 1.4 nm previously reported by Schwabe & Trost (1980) and Lohse et al. (1984) respectively. Hypothyroidism did not appreciably change the KD for [3H]PIA binding (3.8 nM) and insignificantly decreased the Bmax by 14 % to 518 fmol/mg. Again, a one-site model of binding was found to be the most appropriate (r = -0.94, P < 0.001 for the Scatchard plot). These findings imply that the increased responsiveness of the cyclase to inhibition by PIA cannot be attributed to an increase in Al adenosine receptor number; rather, the implication is that hypothyroidism has brought about a post-receptor change.
In this respect it is noteworthy that [3H]PIA binding to isolated fat-cell plasma membranes is also decreased in this animal model of hypothyroidism (Chohan et al., 1984) . Re-examination of the data in Fig. 4 General discussion and conclusions This study shows that hypothyroidism increases the effectiveness of an inhibitory agonist at brain adenylase cyclase. This is achieved without any increase in the abundance of the agonist receptor and without any change in the basal or the forskolin-stimulated adenylate cyclase activity. The changes that are observed, i.e. enhanced inhibition of the cyclase by GTP (in the presence of Na+) and increased effectiveness of GTP in modifying agonist displacement curves, suggest that altered function or abundance of the coupling G-protein is involved. In the case of the fat-cell system, an increased abundance of the a-subunit of Gi is already established in hypothyroidism. Further studies should be directed towards investigating this possibility in the synaptosomal membrane system. If the coupling G-protein is the major locus of change in hypothyroidism, then it is to be expected that inhibition of brain adenylate cyclase through receptors other than the A, adenosine receptor [e.g. opiate (Blume et al., , 1980 Cooper et al., 1982; Koski et al., 1982) or muscarinic cholinergic ] would also be enhanced in this state. This may have general consequences with regard to presynaptic inhibition of neurotransmitter release and could contribute to the coexistence of depression with thyroid dysfunction (Gold et al., 1981; Reus, 1986) . With specific regard to the effects of adenosine, the extracellular production of this agonist is also likely to be enhanced in hypothyroidism, at least in some brain regions, since the activity of the 5'-nucleotidase ectoenzyme in synaptosomal membranes is considerably increased (Mazurkiewicz & Saggerson, 1989) . Increased availability of the agonist together with more effective coupling of its receptor to the adenylate cyclase would be expected to enhance the neuromodulatory effects of adenosine in hypothyroidism. D. M. was supported by a studentship from the Medical Research Council.
